QA: Tyra Biosciences Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001863127_2022_Tyra_Biosciences_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001863127')"}

Graph

Absolute values for 0001863127, Tyra Biosciences Inc.

  xvar xval
0 AssetsCurrent 304,057,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,027,000
3 remainder_Assets 1,617,000
4 LiabilitiesCurrent 3,616,000
5 LiabilitiesNoncurrent 1,348,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,652,000
9 ResearchAndDevelopmentExpense 20,636,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -6,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 306,701,000
1 Liabilities 4,964,000
2 Expenses 26,288,000
3 Revenues 0
4 StockholdersEquity 301,737,000
5 NetIncome -26,294,000
6 ComprehensiveNetIncome -26,294,000
7 BaseVar 168,979,500
8 EconomicCapitalRatio 3.16

Edgar->Model Mapping

Feature Distribution

Change over Time